Try our Advanced Search for more refined results
Searching dockets in Myokardia Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
ANDA Form
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/01/2026. Date of Expiration of Patent: U.S. Patent No. 9,585,883 expires on 6/19/2034; and U.S. Reissue Patent RE50,050 expires on 4/28/2036.Thirty Month Stay Deadline: 10/28/2029. (jfm)
Summons Issued
Summons Issued as to Aurobindo Pharma Ltd. on 7/14/2026; Aurobindo Pharma USA, Inc. on 7/14/2026. (Attachments: # 1 Summons Issued, Aurobindo Pharma USA, Inc.)(jfm)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.